NASDAQ · CGC

Canopy Growth Corporation Common

$0.92 +$0.04 (+4.02%) 1D After hours
Session Pulse Pre-market 1 mentions on Sat No new SEC filings since Mon close its sector ranked 5/11 this week Full pulse →

Key Metrics

$375.13M
Market cap
P/E · TTM
Revenue · TTM
Net income
EPS · TTM
Dividend yield
Free cash flow −$69.14M
Beta · 1Y 1.98
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 24
    From its Apr 22 high, the share price fell 36%.

    Peak close $1.38 on Apr 22; trough close $0.89 on Jul 24. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -36%
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Apr 23
    The stock moved -11.6% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 23
  • Apr 22
    The stock moved +21.1% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 22

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$375.13M
Enterprise value$243.80M
Shares outstanding422.2M
52-wk range$0.84 – $2.38
Avg volume · 20D6.0M
Net cash $131.32M
Book value / share$1.65
IndustryMedicinal Chemicals & Botanical Products
ExchangeNASDAQ
About Canopy Growth Corporation Common
IPO dateApr 7, 2014
Employees1128

Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating
Net
FCF
ROE / ROIC — · —

Financial Health

Current ratio3.34
Quick ratio2.64
Debt / equity0.33
Debt / EBITDA
Net cash $131.32M
Working capital$371.02M

Cash Flow · TTM

Operating CF −$63.81M
Capex −$5.33M
Free cash flow −$69.14M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

4 / 9
Middling fundamentals · 4 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings